Answers are grounded in this paper and cite their sources.
Sir, KPC-producing Klebsiella pneumoniae strains have become the most frequent class A carbapenemase-producing pathogens worldwide. Since the first KPC, described in 2001 in the USA, there are currently 10 KPC-type enzymes (KPC-2 to KPC-11) (http://www.lahey.org/studies); among them KPC-2 and KPC-3 variants are the most common in clinical specimens, accounting for most epidemic outbreaks in the USA and Europe. Dissemination of KPC-producing K. pneumoniae is associated with a highly epidemic international clone of multidrug-resistant (MDR) K. pneumoniae ST258 (where ST stands for sequence type), with susceptibility observed only to colistin, tigecycline and gentamicin.1 Furthermore, recent Italian studies have described the dissemination and the predominance of a KPC-2 variant belonging to ST101.2,3 This MDR clone has recently acquired a new resistance determinant, the 16S rRNA methylase ArmA, encoded by the armA (aminoglycoside resistance methyltransferase) gene, conferring the extensively drug-resistant (XDR) phenotype. The armA gene was found on the same plasmid of the KPC-2 strains previously isolated in Italy3 and China4 and on different plasmids in isolates from Poland.5 In the present study, we describe five K. pneumoniae isolates from five patients in two Italian hospitals (IRCCS Neurolesi, Messina, and Careggi Hospital, Florence) harbouring blaKPC-2 and armA genes in isolates of ST101 belonging to a clonal complex different from those containing the habitual sequence clone ST258 isolated in Italy.6,7 The identification and antimicrobial susceptibility testing of the five isolates were preliminarily performed by the Vitek 2 system (bioMérieux, Marcy l'Étoile, France). The identified species level was centrally reconfirmed by API 20E (bioMérieux) and the MICs were determined using the broth microdilution method, interpreted according to EUCAST guidelines (v.3.1, 2013). These isolates presented a profile of XDR; two of them were resistant to all classes of antibiotics except tigecycline and colistin and three were resistant to colistin. All strains were also highly resistant to gentamicin, amikacin and kanamycin (MICs between 128 and ≥512 mg/L) in addition to carbapenems (Table 1). Clinical characteristics of patients and antibiotic susceptibility of KPC-2- and ArmA-producing K. pneumoniae IPM, imipenem; MEM, meropenem; ETP, ertapenem; TZP, piperacillin/tazobactam; FEP, cefepime; CAZ, ceftazidime; CTX, cefotaxime; CST, colistin; TGC, tigecycline; LVX, levofloxacin; GEN, gentamicin; AMK, amikacin; KAN, kanamycin. aMICs were determined using the broth microdilution method. Clinical characteristics of patients and antibiotic susceptibility of KPC-2- and ArmA-producing K. pneumoniae IPM, imipenem; MEM, meropenem; ETP, ertapenem; TZP, piperacillin/tazobactam; FEP, cefepime; CAZ, ceftazidime; CTX, cefotaxime; CST, colistin; TGC, tigecycline; LVX, levofloxacin; GEN, gentamicin; AMK, amikacin; KAN, kanamycin. aMICs were determined using the broth microdilution method. Multilocus STs, determined according to the protocol described on the K. pneumoniae multilocus sequence typing (MLST) web site (http://www.pasteur.fr/recherche/genopole/PF8/mlst/Kpneumoniae.html),7 revealed that all isolates belonged to ST101, an ST already found in other Italian hospitals.2,3 Our five ST101 strains also possessed an identical macrorestriction profile by PFGE, performed after XbaI digestion, demonstrating the strong epidemic character of this clone.7 In order to fully characterize the profile of resistance of these strains, amplification and sequencing for detection of carbapenemases (KPC, IMP, VIM and OXA), extended spectrum β-lactamases (ESBLs; TEM, SHV and CTX-M)8 and aminoglycoside-modifying enzymes (AAC, APH, AAD and 16S methylase) was performed using previously described primers.5,9 All strains harboured KPC allele 2, TEM-1, APHA1 and ArmA, contributing to the complex phenotype of resistance of these strains. To better characterize the localization of KPC-2, which was found as part of the 10 kb Tn3-like element Tn4401, PCR assays with specific primers for Tn4401 were performed.10 Amplicon sequencing revealed that the blaKPC-2 gene was in all cases embedded in a Tn4401-like transposon. Published papers have reported that Tn4401 has been found on IncN and IncFIIk plasmids (pKpQIL-IT, S9, S12, S15, pKPN101-IT); therefore, for the detection of these plasmids, we used the following primers: S9-F, 5′-GCATTGACCTTGGCATCTTC-3′; S9-R, 5′-GTGATTTACACCACCACCTCATCA-3′; S12-F, 5′-CGGACGGTTGATCAGAATCGGATG-3′; S12-R, 5′-ATTGCTGCTGTAGGGGCTGTCATTCT-3′; S15-F, 5′-GGGGATCGGTTTTCGCCAGCA-3′; S15-R, 5′-GCTTTACCGAGGGAGAATGGCTACTG-3′; pSLMT-F, 5′-GCATTGACCTTGGCATCTTC-3′; pSLMT-R, 5′-CTAATAAACTGGTGCTCGGACAGA-3′; pNYC-F, 5′-GCATCAAACGGAAGCAAAAG-3′; pNYC-R, 5′-CTTAGCAAATGTGGTGAACG-3′; pKpQIL-IT-F, 5′-GGTTATTGGGTGAGGTAAGCATTAGGCG-3′; and pKpQIL-IT-R, 5′-GAGTGAGCGAGGAAGCACCAGGG-3′—designed on the basis of published sequences and specific for each plasmid (GenBank accession numbers FJ223607.1, FJ223605.1, FJ223606.1, HQ589350.1, EU176011.1 and GU595196.1, respectively).10 In all strains amplicon sequence analysis (1071 bp) showed that plasmid sequences matched the pKpQIL-IT plasmid, circulating in Italy and already detected in a strain of K. pneumoniae ST258 background.6 Furthermore, as regards the coexistence of methylase armA in KPC-producing K. pneumoniae, already found to be associated on pETKp90 and pETKp50 plasmids and on the same pKP048 plasmid,4,5 Southern blot experiments on genomic and plasmid DNAs with the blaKPC, armA and pKpQIL-IT probes obtained by PCR fragments were performed. A hybridization signal on the same fragment of 97 kb in all strains was found, suggesting that these genes are located on the same element. Further studies are in progress in our laboratory in order to identify the element carrying the armA gene. In conclusion, our findings suggest that KPC-2- and ArmA-producing K. pneumoniae strains are emerging in an ST101 background. These clones are extensively resistant, also due to lateral gene transfer, rendering all families of drugs useless and requiring only antibiotic combinations (G. Ceccarelli, M. Falcone, A. Giordano, M. L. Mezzatesta, C. Caio, S. Stefani and M. Venditti, unpublished results). Furthermore, the diffusion of these epidemic clones requires the activation of infection control procedures. This work was supported by Italian Minister of Universities funding (to S. S. and M. L. M.). None to declare. We express our gratitude to Antony Bridgewood for language revision.
No takes yet. Share an insight, caveat, or question.
Mezzatesta et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: